Technical analyst Kush Bohra has released his latest high-conviction trading ideas for the upcoming session, featuring stock picks across multiple sectors including financial services, specialty chemicals, and healthcare technology. According to reports from Essential Business Intelligence, Bohra's recommendations span these three key sectors with specific technical setups and target levels for each stock, with the analyst remaining bullish on Aditya Birla Capital, IKS Health, and Navin Fluorine citing favourable technical setups and momentum indicators that could drive near-term gains.
In the financial services space, Aditya Birla Capital shows encouraging signs of strength on the charts and could continue its upward trajectory in the coming sessions. As reported by Essential Business Intelligence, the stock has been witnessing positive momentum and the analyst expects buying interest to remain intact as long as it sustains above key support levels. Bohra recommends buying the stock with specific target levels of ₹406 and ₹419, while setting a stop loss at ₹383 to manage downside risk, offering an attractive risk-reward profile for short-term traders looking to capitalize on momentum in the financial services segment.
Within the healthcare technology segment, IKS Health continues to display a robust technical structure, making it one of Bohra's preferred picks. According to reports from Essential Business Intelligence, the stock has maintained a positive trend and could witness further upside if current momentum persists. The analyst expects the stock to extend its gains over the near term, with traders advised to maintain strict stop-loss discipline to manage risk effectively, ensuring that the technical structure remains intact for continued upward movement.
In the specialty chemicals space, Navin Fluorine International has emerged as another technically attractive opportunity with the analyst believing the stock's chart pattern supports further upside movement. As reported by Essential Business Intelligence, the stock remains one of Bohra's preferred plays within the specialty chemicals sector due to its favourable technical positioning and potential breakout prospects. The analyst advises that buyers are likely to remain active at current levels, with the stock offering strong technical indicators for potential upside toward the ₹7,950 mark, while maintaining a stop loss at ₹7,575 to manage risk effectively.
